Schroder Investment Management Group Reduces Stake in iRhythm Technologies

The investment firm cut its position in the medical technology company by 25.8% in the third quarter.

Mar. 13, 2026 at 9:36am by Ben Kaplan

Got story updates? Submit your updates here. ›

Schroder Investment Management Group reduced its stake in iRhythm Technologies (NASDAQ:IRTC) by 25.8% in the third quarter, according to a recent SEC filing. The firm now owns 164,066 shares of the company's stock, valued at $27.81 million.

Why it matters

iRhythm Technologies is a leading provider of wearable cardiac monitoring devices and data analytics services. The company's flagship product, the Zio patch, is widely used by cardiologists to detect and diagnose heart rhythm disorders. Schroder's reduced position in the stock could signal a shift in investor sentiment around the company.

The details

According to the SEC filing, Schroder Investment Management Group sold 56,903 shares of iRhythm Technologies during the third quarter, reducing its total position to 164,066 shares. The firm now owns approximately 0.51% of the company's outstanding shares.

  • Schroder Investment Management Group filed the SEC report in the 3rd quarter of 2026.

The players

Schroder Investment Management Group

A global asset management firm that provides investment products and services to institutional and retail clients worldwide.

iRhythm Technologies

A medical technology company that develops and commercializes wearable cardiac monitoring devices and associated data analytics services.

Got photos? Submit your photos here. ›

The takeaway

Schroder's reduced stake in iRhythm Technologies could signal a broader shift in investor sentiment around the company, which may have implications for the stock's performance going forward. However, the company's core products and services continue to be in high demand, suggesting that iRhythm remains a strong player in the cardiac monitoring market.